032300 — Korea Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for Korea Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	5,528	3,159	6,368	-1,119	83.8
Depreciation
Amortisation
Non-Cash Items	4,729	3,586	1,054	8,899	7,707
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-4,357	-9,840	-2,607	-1,881	-5,785
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	7,544	-874	7,192	8,279	4,819
Capital Expenditures	-2,179	-2,644	-3,450	-2,752	-2,677
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	635	-2,067	-9,458	-49,124	47,576
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,544	-4,711	-12,908	-51,875	44,899
Financing Cash Flow Items	-439	—	—	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-2,779	12,005	45,363	-4,563	-16,661
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3,247	6,421	39,675	-48,150	33,034